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Abstract
Background: Enzymatic NADH or NADPH-dependent reduction is a widely applied approach for the synthesis of
optically active organic compounds. The overall biocatalytic conversion usually involves in situ regeneration of the
expensive NAD(P)H. Oxidation of formate to carbon dioxide, catalyzed by formate dehydrogenase (EC 1.2.1.2; FDH),
presents an almost ideal process solution for coenzyme regeneration that has been well established for NADH.
Because isolated FDH is relatively unstable under a range of process conditions, whole cells often constitute the
preferred form of the biocatalyst, combining the advantage of enzyme protection in the cellular environment with
ease of enzyme production. However, the most prominent FDH used in biotransformations, the enzyme from the
yeast Candida boidinii, is usually expressed in limiting amounts of activity in the prime host for whole cell
biocatalysis, Escherichia coli. We therefore performed expression engineering with the aim of enhancing FDH
activity in an E. coli ketoreductase catalyst. The benefit resulting from improved NADH regeneration capacity is
demonstrated in two transformations of technological relevance: xylose conversion into xylitol, and synthesis of
(S)-1-(2-chlorophenyl)ethanol from o-chloroacetophenone.
Results: As compared to individual expression of C. boidinii FDH in E. coli BL21 (DE3) that gave an intracellular
enzyme activity of 400 units/gCDW, co-expression of the FDH with the ketoreductase (Candida tenuis xylose
reductase; XR) resulted in a substantial decline in FDH activity. The remaining FDH activity of only 85 U/gCDW was
strongly limiting the overall catalytic activity of the whole cell system. Combined effects from increase in FDH gene
copy number, supply of rare tRNAs in a Rosetta strain of E. coli, dampened expression of the ketoreductase, and
induction at low temperature (18°C) brought up the FDH activity threefold to a level of 250 U/gCDW while reducing
the XR activity by just 19% (1140 U/gCDW). The E. coli whole-cell catalyst optimized for intracellular FDH activity
showed improved performance in the synthesis of (S)-1-(2-chlorophenyl)ethanol, reflected in a substantial, up to
5-fold enhancement of productivity (0.37 g/gCDW) and yield (95% based on 100 mM ketone used) as compared to
the reference catalyst. For xylitol production, the benefit of enhanced FDH expression was observed on
productivity only after elimination of the mass transfer resistance caused by the cell membrane.
Conclusions: Expression engineering of C. boidinii FDH is an important strategy to optimize E. coli whole-cell
reductase catalysts that employ intracellular formate oxidation for regeneration of NADH. Increased FDH-activity
was reflected by higher reduction yields of D-xylose and o-chloroacetophenone conversions provided that mass
transfer limitations were overcome.
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Enzymatic reductions are widely used for the preparation
of single-isomer alcohols, amino acids and other fine che-
micals. Reductases and dehydrogenases applied in biocata-
lysis usually utilize NADP(H) or NAD(H) as cofactors.
The in situ recycling of the high priced and labile coen-
zymes remains a dictate of economic considerations.
Candida boidinii formate dehydrogenase (CbFDH) has
been employed as a workhorse for NADH-regeneration
for decades and is used in one of the biggest processes of
chiral synthesis, the production of tert-L-leucine [1,2]. The
irreversible oxidation of formate to carbon dioxide pulls
coupled reactions to complete conversion and therefore
turned out as an optimal solution from a process point of
view. Moreover principles of green chemistry are met by
the low molecular weight co-substrate formate whose oxi-
dation product CO2 is innocuous and evaporates from the
reaction mixture. The general sensitivity of the known
FDHs to organic solvents, however, prevents use of FDH
in conversion of substrates with low water solubility.
Recombinant E. coli strains co-expressing FDH and a
reductase provide whole-cell biocatalysts that offer the
advantage of protecting the enzyme against adverse med-
ium effects in the cellular environment [3,4]. Whole cell
bioreduction systems allow furthermore the production of
the required activities for carbonyl reduction and coen-
zyme recycling by single bioreactor cultivation without
further enzyme isolation. Efficiencies of whole cell reduc-
tions depend therefore on intracellular activities of the
reductase and the cofactor recycling dehydrogenase. Pre-
viously reported E. coli whole cell catalysts based on
CbFDH were limited by low FDH activity in E. coli, espe-
cially under conditions of high reductase co-expression.
CbFDH is therefore rarely used in whole cell systems [3-6]
whereas many papers have been published on the corre-
sponding conversions catalyzed by free enzymes.
The aim of the present work was to improve a pre-
viously developed whole cell biocatalyst based on Candida
tenuis xylose reductase (CtXR) by boosting the intracellu-
lar CbFDH-level [3,4]. Strains differing in coenzyme recy-
cling capacity were constructed and tested for
productivities and yields in the production of two indust-
rially relevant chemicals, xylitol and (S)-1-(2-chlorophenyl)
ethanol. The exceptional substrate promiscuity of CtXR
allowed the application of two reporter systems differing
to a great extent in reactivity, polarity and toxicity. We
thereby could show that limitations in whole cell reduc-
tions are strongly case-specific and substrate-dependent.
Reduction yields obtained with whole cells as compared to
cell free extracts permitted investigation of the role of
mass transfer in the case of hydrophilic xylose whereas
information on enzyme protection was provided when
working with toxic o-chloroacetophenone.
Results and Discussion
E. coli has been known to accumulate recombinant protein
to a level of up to 50% of the total cell protein [7]. Because
of this very high protein production capacity, E. coli is the
most widely used host organism in whole-cell biotransfor-
mations. However, the design of E. coli whole cell catalysts
for ketone reduction must consider the complication that
the activity of the ketoreductase should be balanced to the
activity of the dehydrogenase applied for coenzyme regen-
eration. Finely tuned co-expression of the genes of interest
is therefore required and standard solutions are currently
not available to achieve this goal. We have shown in prior
work that in E. coli cells expressing CbFDH next to CtXR,
the activity of CbFDH was 4.8-fold lower in comparison to
the activity produced under CbFDH-only expression con-
ditions [3,4]. We have carried out this study with the aim
of eliminating through the application of different strate-
gies of cell and expression engineering the bottleneck of
NADH regeneration in E. coli whole cells containing
CbFDH and CtXR. Gene copy number, promoter strength,
codon usage, mRNA stability and translation velocity were
factors taken into consideration.
Optimization of CbFDH production under single-gene
expression conditions
When expressed from the previously described plasmid
vector pBTac1, production of CbFDH in E. coli JM109
resulted in an activity of 408 U/gCDW (Table 1, JM109_
FDH). Based on a specific activity of 4.4 U/mg for purified
CbFDH, it was estimated from the protein content in the
E. coli extract that CbFDH had accumulated to about 18%
of the total soluble protein. These numbers [8] serve as
reference in the evaluation of the new E. coli constructed
in this work.
Effects of gene copy number and promoter strength
The vector pBTac1 is used for protein expression of
medium strength in E. coli. Target genes are cloned
Table 1 FDH activities measured in the crude cell extracts
of single- and co-expression strains at two induction
temperatures




JM109_FDH 408 (reference, [8]) n.d.




BL21_XR_FDH 85 ± 12
2 110 ± 20
2
BL21_XR_2FDH 146 ± 30
1 186 ± 30
2
Rosetta_XR_FDH 100 ± 18
1 138 ± 23
2
Rosetta_XR_2FDH 202 ± 21
1 251 ± 50
2
1n ≥ 3;
2n ≥ 7; n.d. not determined.
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into the pBR322-derived vector. The moderate to high
strength of the tac promoter is compromised by a low
gene dosage of 15 -20 copies per cell [7]. The used
strain JM109 is designed as cloning strain and generally
not used as high level protein expression strain. Ec o l i
expression strains are deficient in two key proteases
whereas JM109 lacks only one of these protease activ-
ities [9,10]. An increase in copy number and enhance-
ment of promoter strength were considered as potentially
useful strategies for improved CbFDH production. We
chose pRSF-1b, an expression system for protein expres-
sion of up to 50% of the total E. coli protein due to a copy
number of > 100 and the strong T7lac promoter. The con-
structed pRSF-1b_FDH was transformed into BL21 (DE3),
a host providing the T7 polymerase in trans and lacking
key proteases [9,10]. Recombinant enzyme production in
E. coli BL21 (DE3) gave an activity (402 U/gCDW) essen-
tially identical to that of the reference activity (Table 1,
JM109_FDH). These results suggested that the amount of
transcript formed is not the main limitation in the expres-
sion of CbFDH in E. coli. In prokaryotic cells, ribosomes
translate mRNAs that are still being transcribed from DNA
and thereby protect mRNAs from degradation. Fast mRNA
synthesis by the T7 system, however, uncouples transcrip-
tion from translation in E. coli and exposed mRNA is sub-
ject to enzymatic degradation [11]. We therefore studied
the effect of improved mRNA stability.
Effect of enhanced mRNA stability
The average half-life of mRNA in E. coli at 37°C ranges
from seconds to maximally 20 min, and the expression
rate depends directly on the inherent stability of the
mRNA [12]. Increased mRNA lifetime might thus trans-
late directly into enhanced CbFDH production. We there-
fore expressed pRSF-1b_FDH in the RNaseE deficient
E. coli strain BL21 star (DE3). RNaseE (rne 131) has been
reported to be a major source of mRNA degradation in
E. coli [9]. Functional expression of CbFDH was improved
by about 14% in E. coli BL21 star (DE3) as compared to
the reference (Table 1, JM109_FDH).
Effect of providing rare tRNAs
Codon usage bias is a frequent problem encountered in
the expression of eukaryotic proteins in E. coli [13].
Sequence analysis of CbFDH revealed 13 especially rare
triplets encoding arginine (agg, aga) and two rare isoleu-
cine codons (ata) [14]. The pRSF-1b_FDH plasmid was
therefore transformed into E. coli Rosetta 2 (DE3), a deri-
vative of BL21 (DE3) that was specially designed to
enhance recombinant production of eukaryotic proteins.
Rosetta strains supply tRNAs for six codons that are rarely
used in E. coli and include the above mentioned arginine
and isoleucine codons. Using expression from pRSF-
1b_FDH in E. coli Rosetta 2 (DE3), we could enhance the
activity of CbFDH by 11% as compared to the reference
(Table 1).
Effect of induction conditions
It has been known that a decrease in induction tempera-
ture can generate positive effects on recombinant protein
production, often resulting from a generally lowered
expression rate or change in the relative rates of protein
folding and aggregation [9]. We examined CbFDH pro-
duction in E. coli strains BL21 (DE3), BL21 star (DE3)
and Rosetta 2 (DE3), using 18°C instead of 25°C during
the induction phase. Table 1 shows that FDH-activities
were raised between 12 and 38% by the application of a
lower induction temperature. The highest CbFDH activ-
ity of 614 U/gCDW was obtained by using a host strain
with improved capability of handling rare codons and
induction at 18°C (Table 1). Optimization of single-
expression led to a 1.5-fold improvement in CbFDH
activity, equal to 28% of the total soluble protein in the
E. coli extract.
Co-expression of CbFDH and CtXR
Expression of two genes from pET-Duet vector
We have previously described the plasmid vector pET-
Duet_XR_FDH for co-expression of CbFDH and CtXR
[3]. This vector was derived from a pET-Duet-1 plasmid
and contained the gene of CtXR and CbFDH inserted in
its first and second multiple cloning site (MCS1, MCS2),
respectively. The order of placement of the two genes
reflected the notion that the second inserted gene is
g e n e r a l l ye x p r e s s e dm o r es t r o n g l yt h a nt h eg e n e
inserted first. MCS1 is missing a T7 terminator which
leads to transcriptional read-through that destabilizes
corresponding mRNAs [9,12]. Enzyme production was
done in E. coli BL21 (DE3), and the XR activity of 1804
U/gCDW was comparable to the activity (U/gCDW)
obtained under single gene expression conditions using
a pET11a plasmid vector in E. coli BL21 (DE3) [15].
The FDH activity, by contrast, was just about one-fifth
(85 U/gCDW) of the activity obtained under single gene
expression conditions using pBTac1 in E. coli JM109
(Table 1, strain BL21_XR_FDH) [8].
Equal gene copy number and promoter strength pro-
vided by pET-Duet-1 led to imbalanced reductase and
dehydrogenase activities. Expression of functional
CtXR in BL21_XR_FDH accounts for 30% of soluble
protein in E. coli,7 . 7 - f o l da sc o m p a r e dt oCbFDH. To
improve FDH activity under conditions of CbFDH and
CtXR co-expression, we tried to repress CtXR expres-
sion by gene copy number variations. Moreover, the
host Rosetta 2 (DE3) assured provision of rare codon
tRNAs and culture conditions found to be useful for
FDH production under single gene expression condi-
tions were applied.
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The pBR322-derived replicon of pET-Duet-1 determines a
copy number of approximately 40 per cell [16]. The vector
carries two T7lac promoters preceding MCS1 and MCS2
and an ampicillin resistance gene. Co-expression from
multiple plasmids requires compatible replicons and dif-
ferent antibiotic resistances [16]. The newly constructed
pRSF_FDH contains a RSF1030 replicon and a kanamycin
resistance, both compatible with pET-Duet-1. An increase
in CbFDH gene copy number from ~ 40 to > 140 by co-
transformation of BL21 (DE3) with pETDuet_XR_FDH
and pRSF_FDH resulted in a two-fold increased FDH-
activity from 85 to 146 U/gCDW (Table 1, strain BL21_XR_
2FDH). Transformation of Rosetta 2 (DE3) harbouring the
co-expression plasmid with pRSF_FDH resulted in
202 U/gCDW. A decrease in induction temperature from
25 to 18°C further improved CbFDH activity in the cell
free raw extract to 251 U/gCDW (Table 1, strain Rosetta_
XR_2FDH). This is equal to a 3-fold increase in functional
FDH expression with a concomitant CtXR activity reduc-
tion from 1406 to 1140 U/gCDW (Table 2).
The obtained CbFDH activity of 500 U/gprotein is, to the
best of our knowledge, the highest activity reported for co-
expression strains so far [5,17]. Weckbecker et al.
expressed CbFDH and three further genes from compati-
ble duet-plasmids. The alcohol dehydrogenase and
CbFDH were cloned into the first and second cloning site
of the low copy number plasmid pACYCDuet-1. The host
BL21 (DE3) was co-transformed with pETDuet-1 carrying
the two subunits of the transhydrogenase. The obtained
FDH activity of 210 U/gprotein seems relatively high under
induction conditions for several reasons [5]. First, the low
copy number of the CbFDH gene, second the co-expres-
sion of three further genes and third, the induction tem-
perature of 37°C. However, the three co-expressed genes
are of prokaryotic origin (E. coli transhydrogenase, Lacto-
bacillus kefir alcohol dehydrogenase) whereas eukaryotic
genes are co-expressed in the present study. The com-
bined expression of CbFDH and CtXR in Rosetta 2 (DE3)
adds up to 31% of soluble E. coli protein. Arg codons used
in CbFDH and CtXR (aga, agg; [14]) count among the spe-
cifically rare codons in E. coli and are ~ 10-times more fre-
quently used as compared to its natural occurrence in
E. coli. CbFDH carries furthermore a tandem rare Arg-
codon double repeat (Arg210, Arg211; [14]). Ribosome
stalling at the tandem rare codon double repeat might
account for low CbFDH expression at concurrent high
CtXR production [9]. CbFDH co-expression with CtXR
requires a throttling in protein production velocity most
probably owing to rare arg-codon dependence of both
genes.
The high complexity of protein co-expression compli-
cates the correlation of expression parameter to enzyme
activity. We therefore performed a factorial design to fig-
ure out the most relevant variables influencing CbFDH
activity in co-expression strains. CbFDH activities denoted
in Table 1 served as response variable of a 2
3 factorial
design using type of host, gene copy number and induc-
tion temperature as independent variables. All three fac-
tors turned out as significantly influencing CbFDH activity
by means of statistics. Gene copy numbers were most
important in balancing CbFDH and CtXR co-expression.
Exchange of BL21 by Rosetta 2 and a decrease in induc-
tion temperature from 25 to 18°C showed comparable
effects on CbFDH activity. Effects of interactions between
factors are of minor importance to the CbFDH activity.
(Pareto chart of main effects and interactions between fac-
tors are shown in the Additional file 1.) Bioreductions of
D-xylose and o-chloroacetophenone were used to study
the effect of increased intracellular FDH-activity on initial
rates and productivities.
Bioreductions
CtXR converts its natural substrate D-xylose and xenobio-
tic o-chloroacetophenone with specific activities of 12 and
4.4 U/mg, respectively. Sugar-bioreduction constitutes a
completely different problem in whole cell biocatalysis as
compared to reduction of aromatic ketones. The two main
problems in whole cell biocatalysis - biocatalyst stability
and substrate availability - are differentially affected by
substrates with opposed polarities [3,4]. Whole cell reduc-
tions of hydrophilic xylose and hydrophobic o-chloroace-
tophenone were used to study the effect of increased
FDH-activity under contrary conditions. The correspond-
ing products, xylitol and (S)-1-(2-chlorophenyl)ethanol,
are used in food-processing and pharmaceutical industry.
Table 2 Yields of o-chloroacetophenone reductions catalyzed by E. coli whole-cell biocatalysts variable in XR and FDH
activities
E coli pH XR (U/gCDW) FDH (U/gCDW) Substrate (mM) Yield (mM)
1 Yield (mM)
1, 2
BL21_XR_FDH 7.5 1406 110 100 19 46
Rosetta_XR_2FDH 7.5 1140 251 100 35 67
BL21_XR_FDH 6.2 2226 48 100 27 78
Rosetta_XR_2FDH 6.2 2024 189 100 63 95
1Determined for a reaction time of 8 h.
2Additives: 36 μM Polymyxin B sulphate and 500 μM NAD
+.
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scale and chiral 1-(2-chlorophenyl)ethanols are key inter-
mediates in the synthesis of a novel class of chemothera-
peutic substances (PLK1 kinase inhibitors; [18-20]).
Xylitol production
We compared the strains BL21_XR_FDH and Roset-
ta_XR_2FDH in whole cell reductions of 250 mM D-
xylose (Figure 1). Time courses of xylitol formation were,
within the experimental error, identical for both strains.
Initial rates (rs) of ~50 U/gCDW were calculated from the
linear parts of time courses (0-30 min). After 24 h product
yields of 55% with productivities of 2.0 gproduct/gCDW were
obtained. We and others have previously shown that rates
in whole cell biocatalysis are governed by the activity levels
of enzymes and the substrate availability in the cell
[3,4,21,22]. Similar xylose reduction rates for cells differing
2-fold in cofactor recycling activity suggest a main obstacle
in substrate and/or co-substrate import into the cell. Kaup
et al. used an E. coli whole cell catalyst co-expressing man-
nitol dehydrogenase and a bacterial FDH for the reduction
of fructose. Mannitol yields were limited by the fructose
uptake into the cell. Removal of mass transfer resistance
by the co-expression of a fructose transporter led to a
14-fold increase in yields [21]. Protection of enzymes in
the united cell structure is not required for the conversion
of bio-compatible sugar substrates. We therefore repeated
the bioreductions of xylose with disrupted cells (crude cell
extracts) under otherwise identical conditions. We
obtained rs for xylitol formation of 125 U/gCDW and 263
U/gCDW for BL21_XR_FDH and Rosetta_XR_2FDH,
respectively (Figure 1). The 2.5 and 5-fold increases in rs
obtained with the crude cell extracts as compared to
whole cells identify substrate import into the cell as main
limiting factor. Initial rates agree well with FDH-activities
determined photometrically in the cell free crude extracts
of BL21_XR_FDH (110 U/gcdw) and Rosetta_XR_2FDH
(251 U/gcdw) (Table 1; induction at 18°C). Virtually identi-
cal rs values calculated from bioreductions and photo-
metric FDH assays unmask the cofactor recycling rate as
second limiting factor. The 2-fold higher initial rate and
higher conversion obtained with the FDH optimized strain
directly reflects the FDH-expression level in the cell which
in turn rules out substrate or product inhibitions under
reaction conditions. The combination of mass transfer
relief and cofactor recycling improvement led to a conver-
sion of > 90% with a productivity of 3.4 gproduct/gCDW.
(S)-1-(2-chlorophenyl)ethanol production
We compared E. coli BL21_XR_FDH and the FDH-opti-
mized strain Rosetta_XR_2FDH in whole cell reductions
of 100 mM o-chloroacetophenone. Product concentrations
obtained with BL21_XR_FDH and Rosetta_XR_2FDH
yielded 19 and 35 mM (S)-1-(2-chlorophenyl)ethanol,
respectively (ee > 99.9; Table 2). Reduction of hydrophobic
o-chloroacetophenone was therefore 1.8-fold improved by
the 2.3-fold higher intracellular FDH activity of Roset-
ta_XR_2FDH (Table 2). Standard reactions and activity
measurements were carried out in potassium phosphate
buffer at pH 7.5; isolated xylose reductase however shows
~ 70% higher activities at pH 6.2. By lowering the reaction
pH from 7.5 to 6.2 product yields increased 40% for
the initial strain and 80% for the FDH optimized strain
(Table 2). Higher reduction yields obtained with the FDH-
optimized strain or at a more acidic reaction pH strongly
indicate a permeabilizing effect of o-chloroacetophenone
and its reduction product on E. coli cells. We have pre-
viously shown that the high toxicity of o-chloroacetophe-
none towards biocatalyts restricts the time of E. coli whole
cell reductions to maximally ~5 h due to fast catalyst deac-
tivation [4]. Mass transfer limitations on the one hand and
substrate toxicity on the other hand requires cautious
balancing of cell permeabilization. We used Polymyxin B
sulphate to gently permeabilize the cell envelope and
thereby further accelerate the uptake of ketone and for-
mate. Reduction of mass transfer limitation over the cell
membrane was reflected by increases in product concen-
trations to 78 and 95 mM obtained with BL21_XR_FDH
and Rosetta_XR_2FDH, respectively. The enantiomeric
excess of the product (S)-1-(2-chlorophenyl)ethanol
was >99.9% in all experiments.
(S)-1-(2-chlorophenyl)ethanol formation was elevated
by increasing intracellular FDH- or XR-activities. Pro-
duct yield sensitivity for both enzyme activities suggests
similar specific activities under process conditions.
Reductase activities for o-chloroacetophenone are 2.7-
fold reduced as compared to xylose activities in Table 2.
Figure 1 Bioreductions of D-xylose catalyzed by whole cells
and crude cell extracts of E. coli strains BL21_XR_FDH and
Rosetta_XR_2FDH. Type of catalyst is indicated by symbols: ●
Rosetta_XR_2FDH crude extract; ○ Rosetta_XR_2FDH whole-cell
catalyst; ∇ BL21_XR_FDH crude extract; ▼ BL21_XR_FDH whole-cell
catalyst. Reaction conditions: D-xylose (250 mM), sodium formate
(300 mM), cells (10 gCDW/L), 30°C.
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substrate, which is the solubility limit of o-chloroaceto-
phenone in phosphate buffer and roughly reflects the
available substrate at 100 mM. Formate concentrations
in FDH-activity assays and in whole cell reductions were
≥ 10-fold Kformate (15 mM [8]) and saturating. The for-
mate concentration in whole cell reductions was
adjusted to 150 mM, 50 mM excess regarding the
ketone concentration. Substrate availability seems to
govern the specific activity of the whole cell catalyst not
only in the case of xylose but also with o-chloroaceto-
phenone. A limitation of substrate and co-substrate in
the cell effects the activity of whole cell catalysts differ-
entially, because XR-activity depends linearly on the
ketone concentration (Ko-chloroacetophenone ≥ 10 mM [4]),
whereas a formate concentration of 150 mM is 10-fold
the Kformate.
Conclusions
A particular challenge in the development of ‘designer
bugs’ based on CbFDH is the low level of intracellular
FDH in co-expression strains. Especially high overexpres-
sion of CtXR restricted FDH co-expression to 85 U/gCDW.
We used expression engineering to fine tune formate
dehydrogenase and reductase activity levels in E. coli. Our
strategy was to co-express CtXR and CbFDH based on the
same inducible promoter for both genes but with different
gene copy numbers. We furthermore used an E. coli host
optimized for the expression of eukaryotic genes by sup-
plying tRNAs for six codons that are rarely used in E. coli.
Activities of CtXR and CbFDH were - after optimization
of induction - 1140 U/gCDW and 251 U/gCDW, respectively.
Improved FDH-activity result e di nf u l lc o n v e r s i o no f
250 mM D-xylose and 100 mM o-chloroacetophenone
provided that mass transfer limitations are negligible. Full
exploitation of higher FDH-activities required elimination
of cell wall obstacle in the reduction of D-xylose. Hydro-
phobic o-chloroacetophenonen and (S)-1-(2-chlorophenyl)
ethanol that destroy free CtXR and CbFDH within min-
utes [4], permeabilize the cell membrane and thereby facil-
itate substrate uptake. Further permeabilzation was done
with the antibiotic Polymyxin B sulphate. The conversion
of toxic, hydrophobic compounds by whole cells requires
additional reaction engineering to protect the catalyst.
A convenient method is the in situ extraction of hydro-
phobic compounds onto or into non-polar, second phases.
Doig et al. (2002) have previously shown that the inhibi-
tory effect of the lactone substrate bicycle[3.3.0]hept-2-en-
6-one was overcome by a combination of substrate feeding
and in situ substrate supply [23]. Strategies to overcome
low cell activities and stabilities under process conditions
comprise therefore expression engineering, elimination of
mass transfer resistances and protection of the catalyst.
Methods
Chemicals
NADH (sodium salt; ≥98% pure), NAD
+ (free acid; ≥97.5%
pure), D-xylose, and ampicillin were purchased at Roth
(Karlsruhe, Germany). Sodium formate, Polymyxin B sul-
phate, kanamycin, chloramphenicol, and o-chloroaceto-
phenone were obtained from Sigma-Aldrich (Vienna,
Austria). B-Per
® Reagent was from Pierce (Rockford, IL,
USA) and 1-(2-chlorophenyl)ethanol from Alfa Aesar
(Karlsruhe, Germany). Pfu DNA polymerase was from
Promega (Madison, WI, USA). dNTPs, T4 DNA ligase
and restriction enzymes were obtained from MBI Fermen-
tas (Flamborough, ON, Canada). Primers were synthesized
by Invitrogen (Carlsbad, California, USA). Vectors pRSF-
1b and pETDuet-1 were purchased at Novagen (VWR
International GmbH, Vienna Austria). All other chemicals
were from Sigma-Aldrich/Fluka or Roth, and were of the
highest purity available.
Strains and plasmids
The E. coli strains used were JM109 from Promega (Madi-
son, WI, USA), BL21 (DE3) and Rosetta 2 (DE3) from
Novagen (VWR International GmbH, Vienna, Austria)
and BL21 star (DE3) from Invitrogen (Carlsbad, California,
USA). All DNA manipulations and bacterial transforma-
tions were carried out according to standard protocols.
The construction of the E. coli BL21 (DE3)
(BL21_XR_FDH) harbouring CtXR and CbFDH genes on
a pETDuet-1 vector (pETDuet_XR_FDH) was described
elsewhere [3]. The CbFDH gene was amplified from pET-
Duet_XR_FDH by a PCR using Pfu DNA polymerase and
primers providing PagI (compatible ends to NcoI) and
AvrII restriction sites.
Forward primer: 5’-G G T G G T TCATGAAGATCGTTT-
TAG- 3’
Reverse primer: 5’- GTAAACACGATAAGAAA-
TAACCTAGGGGTGGT- 3’
The CbFDH gene was cloned into the multiple clon-
ing site of pRSF-1b (NcoI, AvrII) prior to verification of
correct integration by sequencing (pRSF_FDH). Bacterial
transformation followed a standard electroporation pro-
tocol. For single-expression of CbFDH, pRSF_FDH was
transformed into BL21 (DE3), BL21 (DE3) star and
Rosetta 2 (DE3), for co-expression these strains were
co-transformed with pETDuet_XR_FDH. Constructs are
summarized in Table 3.
Cultivation of strains
E. coli strains were grown in 1000 mL baffled shaken
flasks containing 200 mL of LB media supplemented
with antibiotics according to Table 3. Flasks were sha-
k e na t1 3 0r p ma n d3 7 ° Ci naC e r t o m a t
® BS-1 incuba-
tor from Sartorius. At an optical density of 1.1 (± 10%)
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tion was induced by addition of 250 μM isopropyl-b-D-
thiogalactopyranosid (IPTG). After 20 h of cultivation,
cells were harvested by centrifugation. Samples were
taken and the B-Per
® cell lysis reagent was used for pro-
tein extraction prior to enzyme activity measurements.
Enzyme activity measurements in the cell-free extract
Reductase and dehydrogenase activities were assayed spec-
trophotometrically at 340 nm by monitoring the reduction
or oxidation of NAD(H) over a time period of 5 minutes
(rates of 0.05 - 0.10 ΔA/min). One unit of enzyme activity
refers to 1 μmol of NAD(H) consumed or formed per
minute. All activity measurements were performed with a
Beckman DU-800 spectrophotometer thermostated at
25°C. Xylose reductase activity was either determined with
the native substrate D-xylose (700 mM) or with o-chloroa-
cetophenone (10 mM). Reactions were started with addi-
tion of NADH in a final concentration of 310 μM. The
assay for formate dehydrogenase activity contained
200 mM sodium formate and the reaction started with the
addition of 2 mM NAD
+. Activity assays were performed
in 100 mM potassium phosphate buffer, pH 7.5 or 6.2.
Five % ethanol was added to the buffer to enhance the
solubility of o-chloroacetophenone. Measured rates were
corrected for the appropriate blank readings accounting
for non-specific oxidation or reduction of NAD(P)(H) by
the cell extracts.
Whole-cell bioreductions
Experiments were carried out at 30°C on an end-over-
end rotator (SB3 from Stuart) at 30 rpm.
D-Xylose
Biomass of each strain was divided into halves. One half of
the cell material was diluted to 10 gCDW/L with 100 mM
potassium phosphate buffer pH 7.5. 10 mL of the cell sus-
pension were filled into a 15 mL Sarstedt tube with
300 mM co-substrate sodium formate added. The second
half of the cells were disrupted by three passages through
a French press (American Instrument Company, Silver
Springs, Maryland, USA) operated at an applied pressure
of 1000 psi. The crude cell extracts obtained were diluted
with 100 mM potassium phosphate buffer, pH 7.5 to a
concentration equivalent to 10 gCDW/L. After ultra-centri-
fugation, 10 mL of supernatant was transferred into a
15 mL Sarstedt tube and supplemented with 300 mM
sodium formate and 500 μMN A D
+. Conversions were
started by the addition of 250 mM xylose. 200 μL samples
were taken over time and the reaction was stopped after
24 h by the addition of ethanol in a 1:1 (v/v) ratio. Centri-
fugation separated the biomass and the product-contain-
ing supernatant was prepared for high performance liquid
chromatography (HPLC).
o-Chloroacetophenone
E. coli cells were diluted to a concentration of 40 gCDW/L
with 100 mM potassium phosphate buffer of either pH 7.5
or 6.2. The co-substrate sodium formate was added in a
concentration of 150 mM, 50 mM excess as compared to
the substrate o-chloroacetophenone. Reactions were
started by the addition of o-chloroacetophenone which
was pre-dissolved in ethanol to enhance its solubility. Final
ethanol concentrations were 5%. Polymyxin B sulphate
and NAD
+ were added in concentrations of 36 and
500 μM, respectively, to the reaction mix. Total reaction
volumes were 1 mL and bioreductions of o-chloroaceto-
phenone were performed in 2 mL Eppendorf tubes. After
eight hours reactions were stopped by the addition of
ethanol in a 1:1 (v/v) ratio. Cells were then separated by
centrifugation and the supernatant was analyzed by chiral
HPLC.
Analytical methods
HPLC-analysis of whole-cell reductions was performed
on a LaChrom HPLC system (Merck-Hitachi) equipped
Table 3 E. coli expression strains addressed in this study
E. coli host Plasmid Enzyme Antibiotic Abbreviation
JM109 pBTac1 CbFDH Amp
1 JM109_FDH [8]
BL21 (DE3) pRSF-1b CbFDH Kan
2 BL21_FDH
Rosetta 2 (DE3) pRSF-1b CbFDH Cam
3, Kan Rosetta_FDH
BL21 star (DE3) pRSF-1b CbFDH Kan Star_FDH
BL21 (DE3) pETDuet-1 CtXR, CbFDH Amp BL21_XR_FDH
BL21 (DE3) pETDuet-1
pRSF-1b
CtXR, CbFDH; CbFDH Amp, Kan BL21_XR_2FDH
Rosetta 2 (DE3) pETDuet-1 CtXR, CbFDH Cam, Amp Rosetta_XR_FDH
Rosetta 2 (DE3) pETDuet-1
pRSF-1b
CtXR, CbFDH; CbFDH Cam, Amp, Kan Rosetta_XR_2FDH
BL21 star (DE3) pETDuet-1
pRSF-1b
CtXR, CbFDH; CbFDH Amp, Kan Star_XR_2FDH
1 Ampicillin 115 mg/L;
2 kanamycin 50 mg/L;
3 chloramphenicol 34 mg/L.
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RI detector, and a thermo-stated column oven.
D-Xylose
Samples were analysed on an Aminex HPX-87H column
(Bio Rad Laboratories, Vienna, Austria) using sulphuric
acid (5 mM H2SO4) as eluent at a flow rate of 0.6 mL/min
and a temperature of 65°C. For xylitol peak identification
and quantification authentic standards with known con-
centrations were measured. Reported yields of xylitol pro-
duct are always from analytical data, product isolation was
beyond the scope of this study.
o-Chloroacetophenone
Samples were analysed on a reversed phase CHIRALPAK
AD-RH column from Daicel (VWR International, Vienna,
Austria) using an acetonitrile-water mixture (20:80 v/v) at
a flow rate of 0.5 mL/min and a column temperature of
40°C. For alcohol peak identification standards with
known concentrations were measured. Reported product
yields are always from analytical data.
Additional material
Additional file 1: Factorial design. CbFDH activity measured in the cell-
free extract was specified as response variable of a 2
3 factorial design.
Type of host (A), number of plasmids (B) and induction temperature (C)
were chosen as experimental factors.
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